BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Denholm JT, McBryde ES. The use of anti-tuberculosis therapy for latent TB infection. Infect Drug Resist 2010;3:63-72. [PMID: 21694895 DOI: 10.2147/idr.s8994] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kovačić D, Softić A, Salihović A, Jotanović J. The Ambiguous Role of Macrophages in Pulmonary Tuberculosis. Macrophages -140 Years of Their Discovery [Working Title] 2022. [DOI: 10.5772/intechopen.104736] [Reference Citation Analysis]
2 Heidary M, Shirani M, Moradi M, Goudarzi M, Pouriran R, Rezaeian T, Khoshnood S. Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment. Eur J Microbiol Immunol (Bp) 2022. [PMID: 35420996 DOI: 10.1556/1886.2021.00021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Postnikov EB, Lebedeva EA, Zyubin AY, Lavrova AI. The Cascade Hilbert-Zero Decomposition: A Novel Method for Peaks Resolution and Its Application to Raman Spectra. Mathematics 2021;9:2802. [DOI: 10.3390/math9212802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kathamuthu GR, Moideen K, Sridhar R, Baskaran D, Babu S. Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis. PLoS One 2021;16:e0253534. [PMID: 34153068 DOI: 10.1371/journal.pone.0253534] [Reference Citation Analysis]
5 Albors-Vaquer A, Rizvi A, Matzapetakis M, Lamosa P, Coelho AV, Patel AB, Mande SC, Gaddam S, Pineda-Lucena A, Banerjee S, Puchades-Carrasco L. Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers. Emerg Microbes Infect 2020;9:1131-9. [PMID: 32486916 DOI: 10.1080/22221751.2020.1760734] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
6 Zhetkenev S, Khassan A, Khamzina A, Issanov A, Crape B, Akilzhanova A, Yerezhepov D, Kozhamkulov U, Chan CK. Association of rs12722 COL5A1 with pulmonary tuberculosis: a preliminary case-control study in a Kazakhstani population. Mol Biol Rep 2021;48:691-9. [PMID: 33409715 DOI: 10.1007/s11033-020-06121-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mayito J, Andia Biraro I, T Reece S, R Martineau A, P Kateete D. Detection of Mycobacterium tuberculosis DNA in CD34 + peripheral blood mononuclear cells of Ugandan adults with latent infection: a cross-sectional and nested prospective study. AAS Open Res 2020;3:34. [PMID: 32832853 DOI: 10.12688/aasopenres.13108.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Leong S, Zhao Y, Ribeiro-Rodrigues R, Jones-López EC, Acuña-Villaorduña C, Rodrigues PM, Palaci M, Alland D, Dietze R, Ellner JJ, Johnson WE, Salgame P. Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB. Tuberculosis (Edinb) 2020;120:101898. [PMID: 32090859 DOI: 10.1016/j.tube.2020.101898] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Rasool MF, Khalid S, Majeed A, Saeed H, Imran I, Mohany M, Al-Rejaie SS, Alqahtani F. Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations. Pharmaceutics 2019;11:E578. [PMID: 31694244 DOI: 10.3390/pharmaceutics11110578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhetkenev S, Khassan A, Khamzina A, Issanov A, Crape B, Akilzhanova A, Kozhamkulov U, Yerezhepov D, Chan CK. Association of rs12722 COL5A1 with Pulmonary Tuberculosis infection: a preliminary case-control study in a Kazakhstani population.. [DOI: 10.1101/19008995] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Dundar C, Oztomurcuk D, Terzi O. Regional success on screening and chemoprophylaxis in contacts of patients with pulmonary tuberculosis in Turkey: a dispensary experience in 2016–2017. Transactions of The Royal Society of Tropical Medicine and Hygiene 2019;113:351-355. [DOI: 10.1093/trstmh/trz008] [Reference Citation Analysis]
12 Vaidya B, Nakarmi S. Simultaneous Adalimumab and Antitubercular Treatment for Latent Tubercular Infection: An Experience from Nepal. Int J Rheumatol 2019;2019:2034950. [PMID: 31057626 DOI: 10.1155/2019/2034950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Vyas SP, Goswami R. Striking the right immunological balance prevents progression of tuberculosis. Inflamm Res 2017;66:1031-56. [PMID: 28711989 DOI: 10.1007/s00011-017-1081-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kabbara WK, Sarkis AT, Saroufim PG. Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature. Case Rep Infect Dis 2016;2016:3617408. [PMID: 27648319 DOI: 10.1155/2016/3617408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Sandgren A, Vonk Noordegraaf-Schouten M, van Kessel F, Stuurman A, Oordt-Speets A, van der Werf MJ. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infect Dis 2016;16:204. [PMID: 27184748 DOI: 10.1186/s12879-016-1550-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
16 Soni V, Upadhayay S, Suryadevara P, Samla G, Singh A, Yogeeswari P, Sriram D, Nandicoori VK. Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen. PLoS Pathog 2015;11:e1005235. [PMID: 26489015 DOI: 10.1371/journal.ppat.1005235] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
17 Denholm JT, McBryde ES, Eisen DP, Penington JS, Chen C, Street AC. Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study. Drug Healthc Patient Saf 2014;6:145-9. [PMID: 25364275 DOI: 10.2147/DHPS.S68837] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]